NEOGEN CORPORATION (NASDAQ:NEOG) Files An 8-K Other Events

0

NEOGEN CORPORATION (NASDAQ:NEOG) Files An 8-K Other Events

Item8.01

Other Events

On January24, 2017, Neogen Corporation announced that it had
terminated its agreement with SenesTech Incorporated (NASDAQ:
SNES) related to the manufacturing and marketing of a rodenticide
being developed by SenesTech. A copy of the press release is
attached as Exhibit 99.1 to this report.

This Form 8-K and the attached exhibit shall not be deemed filed
for purposes of Section18 of the Securities Exchange Act of 1934,
as amended, and are not incorporated by reference into any filing
of the Registrant, whether made before or after the date of this
report, regardless of any general incorporation language in the
filing.

Item9.01 Financial Statements and Exhibits

(d) Exhibits

99.1 Neogen Corporation Press Release dated January24, 2017


About NEOGEN CORPORATION (NASDAQ:NEOG)

Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the production and marketing of products dedicated to animal health, including a range of consumable products marketed to veterinarians and animal health product distributors. The Animal Safety segment also provides genetic identification services. Additionally, the Animal Safety segment produces and markets rodenticides, disinfectants and insecticides to assist in the control of rodents and disease in and around agricultural, food production and other facilities.

NEOGEN CORPORATION (NASDAQ:NEOG) Recent Trading Information

NEOGEN CORPORATION (NASDAQ:NEOG) closed its last trading session up +0.53 at 64.31 with 80,366 shares trading hands.